Clincosm LogoSign in Get a demo

Diabetes

Showing NaN - NaN of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +85 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec/insulin aspart
  • +2 more
  • Phoenix, Arizona
  • +72 more
Jun 3, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Faster-acting insulin aspart
  • +2 more
  • Phoenix, Arizona
  • +154 more
May 22, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Birmingham, Alabama
  • +98 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 1
  • inhaled human insulin
  • +2 more
  • Birmingham, Alabama
  • +95 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Birmingham, Alabama
  • +90 more
Mar 8, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (FlexTouch®, FlexPen®)

Completed
Has Results
  • Diabetes
  • +3 more
  • FlexTouch®
  • FlexPen®
  • Burlingame, California
  • +64 more
Feb 6, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin detemir, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec/insulin aspart
  • +2 more
  • La Mesa, California
  • +80 more
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +85 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Mexico, Puerto Rico, United States (liraglutide, glimepiride, )

Terminated
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +116 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Mesa, Arizona
  • +45 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Northridge, California
  • +98 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Bay Minette, Alabama
  • +186 more
Dec 16, 2016

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Phoenix, Arizona
  • +119 more
Dec 15, 2016

Diabetes, Diabetes, Type 2 Trial in Canada, United States (liraglutide, rosiglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Goodyear, Arizona
  • +88 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin aspart
  • Fresno, California
  • +59 more
Nov 23, 2016

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, insulin glargine, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +3 more
  • Concord, California
  • +26 more
Jan 6, 2017